RIPK1 anticorps (AA 350-400)
Aperçu rapide pour RIPK1 anticorps (AA 350-400) (ABIN207743)
Antigène
Voir toutes RIPK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 350-400
-
Specificité
- A portion of amino acids 350-400 of human RIP1.
-
Purification
- Protein G purified
-
Immunogène
-
A portion of amino acids 350-400of human RIP1.
Type of Immunogen: Protein fragment -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: WB (1 - 3 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
-
Autre désignation
- RIPK1 / RIP
-
Sujet
-
Name/Gene ID: RIPK1
Subfamily: RIP
Family: Protein Kinase
Synonyms: RIPK1, Cell death protein RIP, Receptor interacting protein, RIP1, RIP, RIP-1, Protein kinase rip, Receptor-interacting protein 1, Rinp -
ID gène
- 8737
-
UniProt
- Q13546
-
Pathways
- Signalisation NF-kappaB, Apoptose, Caspase Cascade in Apoptosis, Signalisation TLR, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway
Antigène
-